Dr. Kanwal Raghav, an oncologist at MD Anderson, discusses encouraging results from his phase II immunotherapy trial for peritoneal mesothelioma. He also emphasizes the importance of multidisciplinary teams and why patients should ask about clinical trials as soon as possible.

Tiziana Life Sciences is showcasing its ongoing Phase 2a BANYAN Clinical Trial investigating intranasal foralumab, a fully human anti-CD3 monoclonal antibody, at ALS Nexus 2026. The presentation highlights the potential impact of innovative immunomodulation therapies in addressing ALS.

At age 20, uncertainty about the future can feel paralyzing. This article underscores that “being stuck” isn’t always a sign of failure but can instead be a catalyst for exploration and growth.

When her husband called, his faint, slurred words made it clear something was terribly wrong. In that moment, one urgent word—“ambulance”—reshaped their understanding of resilience and transformed their marriage in an instant.

A personal revelation led one reader to uncover two secret siblings. Through an advice column and thoughtful discussions with readers, she offers insights on how to handle the emotional upheaval and familial reconfigurations that follow such life-changing news.

After four decades of marriage, one wife notices her husband’s puzzling behavior over the past year. A counselor speculates he could be nervous or hiding something, then surprisingly suggests she let it go. The conflicting advice leaves her searching for answers about trust and transparency.

After four decades of marriage, one woman finds herself reeling from her husband’s sudden departure. Now she grapples with a delicate choice: whether to share the painful truth with their adult son or maintain a respectful silence.

Summer travel often brings the promise of adventure, but for some children, it can also mean motion sickness. Whether on the road, on a plane, or enjoying a spinning carnival ride, young travelers can experience nausea and discomfort.

Results from two phase 3 trials—BRUIN CLL-313 and BRUIN CLL-314—indicate that pirtobrutinib is effective in frontline chronic lymphocytic leukemia. Released by Onclive, the findings suggest a promising option for patients who have not received prior treatment, though specific data remain behind a paywall.

Whether it’s a new acquaintance or a distant colleague, we sometimes get an immediate uneasy feeling about people. Advice columnist R. Eric Thomas suggests it’s valid to trust these instincts and reminds us that acknowledging discomfort can protect our well-being.

An 80-year-old patient demonstrated how vital rehabilitation is in rebuilding mobility after a hip replacement. As family members look for best practices, experts focus on supervision needs and adapting care throughout the healing journey.

A mother’s recent custody evaluation reveals why communication with her co-parent has been so difficult. Diagnosed with both autism and narcissistic personality disorder, he presents challenges that now have added context.

Two couples share their marital frustrations in letters to Dear Abby, seeking advice on financial stability, personal hygiene, and emotional support. Dear Abby suggests clear-cut goals, medical evaluations, and legal guidance, reminding readers that sometimes a firm boundary is necessary to preserve a relationship.

Two families are remembering the lives of Ava Starr and Alexis Thornton, who took their own lives. In the wake of these tragic losses, they hope to spark an open and heartfelt conversation about the power of words and the critical need for mental health awareness.

Pasithea Therapeutics will reveal new data on its macrocyclic MEK inhibitor, PAS-004, at the European Society for Medical Oncology (ESMO) Congress in 2026. The presentation promises insight into therapies targeting the MAPK pathway for advanced solid tumors.

An adult grapples with the emotional burden of caring for a mother who was missing throughout childhood. Faced with this history, the writer questions whether to offer support now that the parent is aging.

Neuronata-R, a stem cell therapy, has retained its conditional approval from South Korea’s Ministry of Food and Drug Safety (MFDS) through May 2026. As its developer plans to resume supply, the path forward also includes establishing a U.S. research base.

A 62-year-old woman confronts stage 4 kidney disease after a diagnosis of focal segmental glomerulosclerosis (FSGS) in 2001. Following several years of treatment and a brief remission, she now highlights the importance of preparing for what lies ahead.

Physical therapy focuses on restoring basic movement and ability, while weight training builds on that foundation to cultivate sustained strength. Both methods play vital roles in maintaining a healthy, active lifestyle.

A recent target trial emulation among veterans with type 2 diabetes found that adding GLP-1 receptor agonists to basal insulin therapy did not improve insulin discontinuation rates. Researchers compared the effects of adding GLP-1RAs against adding SGLT-2i or DPP-4i therapy, but saw no significant difference in outcomes.

In Kerrville, Texas, survivors of a recent Guadalupe River flood are turning to counseling offices for help with trauma and grief. Demand for mental health services has soared, and local providers are stepping up to assist those in need of emotional support.